GingiCaine Gel, Chocolate Mint
- Product NDC
- 10129-034
- 11-digit product format
- 101290034
- Labeler code
- 10129
- Product ID
- 10129-034_556cb4b1-8f13-33c6-e063-6294a90a6892
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- GingiCaine Gel, Chocolate Mint Flavor
- Dosage form
- GEL
- Route
- DENTAL; ORAL; PERIODONTAL
- Labeler
- Gingi-Pak a Division of the Belport
- Application
- M022
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 1993-07-06
- Substance
- BENZOCAINE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | I | Inactivated by FDA | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 10129-034-01 | I | Inactivated by FDA | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 10129-034-05 | I | Inactivated by FDA | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 10129-034-01 | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 10129-034-05 | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 10129-034-01 | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 10129-034-05 | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 10129-034-01 | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 10129-034-05 | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 10129-034-01 | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 10129-034-05 | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 10129-034-01 | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 10129-034-05 | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 10129-034-01 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 10129-034-05 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 10129-034-01 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 10129-034-05 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 10129-034-01 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 10129-034-05 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- GingiCaine Gel, Chocolate Mint
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| BENZOCAINE | 200 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| U3RSY48JW5 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 6285c4f2-c139-49a9-e053-2991aa0a2b03 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 362d7abb-94e6-4c60-9a58-266894157713 | Product name | 1 | 20231023 |
| 816b97af-edc5-4060-aff1-b814bdbcad50 | Product name | 1 | 20190415 |
| 419aab54-5d5a-4146-9453-026d4a9991be | Product name | 2 | 20170525 |
| 89dac932-b90a-4410-9ab1-84c53e57de25 | Product name | 1 | 20150316 |
| d723478e-ad4a-ec23-6bd7-cfe33e1e3840 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 10129-034-01 | 2025-01-30 | GingiCaine Gel, Chocolate Mint |
| 10129-034-01 | 2025-01-30 | GingiCaine Gel, Chocolate Mint |
| 10129-034-05 | 2025-01-30 | GingiCaine Gel, Chocolate Mint |
| 10129-034-05 | 2025-01-30 | GingiCaine Gel, Chocolate Mint |
| 10129-034-01 | 2021-09-02 | GingiCaine Gel, Chocolate Mint |
| 10129-034-01 | 2021-09-02 | GingiCaine Gel, Chocolate Mint |
| 10129-034-05 | 2021-09-02 | GingiCaine Gel, Chocolate Mint |
| 10129-034-05 | 2021-09-02 | GingiCaine Gel, Chocolate Mint |
| 10129-034-01 | 2021-07-23 | GingiCaine Gel, Chocolate Mint |
| 10129-034-01 | 2021-07-23 | GingiCaine Gel, Chocolate Mint |
| 10129-034-05 | 2021-07-23 | GingiCaine Gel, Chocolate Mint |
| 10129-034-05 | 2021-07-23 | GingiCaine Gel, Chocolate Mint |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 10129-034-01 | GingiCaine Gel, Chocolate Mint | 1 in 1 BOTTLE, PLASTIC | GEL | 1 | 2 | |
| 10129-034-05 | GingiCaine Gel, Chocolate Mint | 6 in 1 BOTTLE, PLASTIC | GEL | 6 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 10129-034 | GINGICAINE GEL, CHOCOLATE MINT (GINGICAINE GEL, CHOCOLATE MINT FLAVOR) GEL [GINGI-PAK A DIVISION OF THE BELPORT] | 2 | Current NDC, Legacy NDC, 2 package rows | 20211210_6285c4f2-c139-49a9-e053-2991aa0a2b03.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sensitive Mint Tooth-paste | POTASSIUM NITRATE, SODIUM FLUORIDE | Meijer, Inc. | 1e5e8b24-8304-482c-ae80-73effcc345da | 2025-12-23 | Warnings | M022 |
| Sensitive Whitening Tooth-paste | POTASSIUM NITRATE, SODIUM FLUORIDE | Meijer, Inc. | c25b6a95-e604-48e3-bc55-595969d1ce9b | 2025-12-23 | Warnings | M022 |
| parodontax Active Gum Repair | STANNOUS FLUORIDE | Haleon US Holdings LLC | b51ccdd9-c0af-4caa-ad97-ad1d1423b76b | 2025-12-22 | Warnings | M022 |
| parodontax Complete Protection | STANNOUS FLUORIDE | Haleon US Holdings LLC | 59bb84d6-6fd3-4586-bccf-7dc45cbbb39c | 2025-12-22 | Warnings | M022 |
| parodontax Complete Protection | STANNOUS FLUORIDE | Haleon US Holdings LLC | f6912712-ce9b-44aa-8953-b9a8d420f458 | 2025-12-22 | Warnings | M022 |
| parodontax Active Gum Repair Whitening | STANNOUS FLUORIDE | Haleon US Holdings LLC | 817e804c-e55e-4d77-9ab9-ff54ae794725 | 2025-12-22 | Warnings | M022 |
| parodontax Active Gum Repair Breath Freshener | STANNOUS FLUORIDE | Haleon US Holdings LLC | addcb1e2-24b9-4367-adf3-6806e2439a80 | 2025-12-22 | Warnings | M022 |
| parodontax | STANNOUS FLUORIDE | Haleon US Holdings LLC | 0f07aa1a-97be-44af-92d8-a10777e24e0a | 2025-12-22 | Warnings | M022 |
| R B one | PHOSPHATIDYLSERINE, ZINC OXIDE | NPG Bio Pharmaceuticals Co.,Ltd. | 410c40fd-cf94-0301-e063-6294a90ae2de | 2025-12-18 | Warnings | M022 |
| Dem Zero | PHOSPHATIDYLSERINE, MAGNESIUM OXIDE | NPG Bio Pharmaceuticals Co.,Ltd. | 411f1a0f-ed02-cc78-e063-6394a90a0aec | 2025-12-18 | Warnings | M022 |
| Res B one | PHOSPHATIDYLSERINE, ZINC OXIDE | NPG Bio Pharmaceuticals Co.,Ltd. | 21469f58-1d70-774f-e063-6294a90af039 | 2025-12-18 | Warnings | M022 |
| Alzh L | PHOSPHATIDYLSERINE, MAGNESIUM OXIDE | NPG Bio Pharmaceuticals Co.,Ltd. | 41056de0-aaa2-01bb-e063-6394a90af7b8 | 2025-12-18 | Warnings | M022 |
| Lemon | GLYCERIN | TwinMed LLC | fc88eec0-c66c-5d6d-e053-6294a90a13d2 | 2025-12-18 | Warnings | M022 |
| CloSYS | HYDROGEN PEROXIDE | Rowpar Pharmaceuticals, Inc. | 299fc7b1-af6d-4bf9-810f-d35283423fe2 | 2025-12-17 | Warnings | M022 |
| HurriCaine | TOPICAL ANESTHETIC | Beutlich Pharmaceuticals LLC | 255fba91-6357-4414-ad23-a18694ef886b | 2025-12-17 | Warnings | M022 |
| Ipana 20% Benzocaine Topical | BENZOCAINE | Maxill Inc. | c13761e0-d45d-4e0f-ac41-428e005f96bb | 2025-12-17 | Warnings | M022 |
| Ipana 20% Benzocaine Topical | BENZOCAINE | Maxill Inc. | 6dca566b-cb6a-43c4-b6e2-f2bad77fb932 | 2025-12-17 | Warnings | M022 |
| Ipana 20% Benzocaine Topical | BENZOCAINE | Maxill Inc. | f36bb9bd-e9bc-4f35-a388-e0ffadbce6ab | 2025-12-17 | Warnings | M022 |
| Ipana 20% Benzocaine Topical | BENZOCAINE | Maxill Inc. | 7ede08e5-2dfe-4183-905d-28d1cea42407 | 2025-12-17 | Warnings | M022 |
| Ipana 20% Benzocaine Topical | BENZOCAINE | Maxill Inc. | 9de36e4f-f966-4a58-b4bf-9ac3b86b3f09 | 2025-12-17 | Warnings | M022 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 238910 | benzocaine 20 % Oral Gel | PSN | 6285c4f2-c139-49a9-e053-2991aa0a2b03 | 2 |
| 543801 | Gingicaine 20 % Oral Gel | PSN | 6285c4f2-c139-49a9-e053-2991aa0a2b03 | 2 |
| 543801 | benzocaine 0.2 MG/MG Oral Gel [Gingicaine] | SBD | 6285c4f2-c139-49a9-e053-2991aa0a2b03 | 2 |
| 238910 | benzocaine 0.2 MG/MG Oral Gel | SCD | 6285c4f2-c139-49a9-e053-2991aa0a2b03 | 2 |
| 238910 | benzocaine 20 % (180-220 MG per 1 GM) Oral Gel | SY | 6285c4f2-c139-49a9-e053-2991aa0a2b03 | 2 |
| 543801 | Gingicaine 0.2 MG/MG Oral Gel | SY | 6285c4f2-c139-49a9-e053-2991aa0a2b03 | 2 |
| 543801 | Gingicaine 20 % Oral Gel | SY | 6285c4f2-c139-49a9-e053-2991aa0a2b03 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 10129-034-01 | 10129003401 | 1 GEL in 1 BOTTLE, PLASTIC (10129-034-01) | 1 gel | 1993-07-06 | 0000-00-00 | No | No | Current |
| 10129-034-05 | 10129003405 | 6 GEL in 1 BOTTLE, PLASTIC (10129-034-05) | 6 gel | 1993-07-06 | 0000-00-00 | No | No | Current |